Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
126 hedge funds and large institutions have $961M invested in Applied Therapeutics in 2024 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 33 increasing their positions, 31 reducing their positions, and 15 closing their positions.
213% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 15
99% more capital invested
Capital invested by funds: $482M → $961M (+$479M)
34% more funds holding
Funds holding: 94 → 126 (+32)
7.78% more ownership
Funds ownership: 90.38% → 98.16% (+7.8%)
6% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 31
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
2% less call options, than puts
Call options by funds: $17.1M | Put options by funds: $17.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$37.6M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$17.1M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$12.3M |
| 4 |
State Street
Boston,
Massachusetts
|
+$12M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VPC
Vestal Point Capital
New York
|
-$25.3M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$20.1M |
| 3 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$10.7M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$5.8M |
| 5 |
AG
Artal Group
Luxembourg
|
-$4.71M |
APLT Hedge Fund Activity: Q3 2024 in Review
126 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q3 2024, worth a combined $961M — up 99% from $482M a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new APLT positions and 15 closed out — a net gain of 32 holders — while 33 added to existing stakes and 31 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $37.6M. The largest seller was Vestal Point Capital, cutting an estimated $25.3M.
- 126 institutional investors held Applied Therapeutics (APLT) as of Q3 2024, up from 94 in Q2 2024.
- Funds reported $961M of Applied Therapeutics stock for Q3 2024, up 99% quarter-over-quarter.
- 47 funds opened new Applied Therapeutics positions in Q3 2024 and 15 closed out, a net change of +32 holders.
- The largest Applied Therapeutics buyer in Q3 2024 was Morgan Stanley, an estimated $37.6M added.
- The largest Applied Therapeutics seller in Q3 2024 was Vestal Point Capital, an estimated $25.3M sold.
Based on aggregated 13F filings for Q3 2024.